Cost Plus Drug Company vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Mark Cuban Cost Plus Drug Company offers generic prescription medications at transparent cost-plus pricing; has expanded to over 2,500 generic drugs priced at cost plus 15% markup; partners with pharmacies nationwide;
About
Mark Cuban Cost Plus Drug Company (also known as Cost Plus Drugs) is a direct-to-consumer pharmaceutical company co-founded in 2022 by Mark Cuban and Alex Oshmyansky and headquartered in Dallas, Texas. The company disrupts the opaque and often inflated pricing of generic pharmaceuticals by operating on a transparent cost-plus model: it sources generic drugs directly from manufacturers, adds a fixed 15% markup, a $3 pharmacy labor fee, and a $5 shipping fee — publishing the final price for every drug openly on its website. This approach bypasses the traditional pharmacy benefit manager (PBM) system, which critics argue inflates drug prices through rebate structures that benefit intermediaries at the expense of patients and payers.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Cost Plus Drug Company vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.